REVIEW ARTICLE |
|
Year : 2020 | Volume
: 3
| Issue : 2 | Page : 37-44 |
|
An overview of Vatha Sura Kudineer (VSK): A potential Siddha antiviral drug
Shunmugaram Shenbagaraj, Lavanya Alagusolaiyan, Rajendra Kumar Arumugam
Siddha Regional Research Institute, Central Council for Research in Siddha, Puducherry, India
Correspondence Address:
Dr. Shunmugaram Shenbagaraj Siddha Regional Research Institute, Central Council for Research in Siddha, Puducherry 605013 India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/jrsm.jrsm_5_22
|
|
Introduction: The World Health Organization defines that communicable diseases are caused by microorganisms, fungi, insect bites, or contaminated water that can spread directly or indirectly, between persons. Chikungunya is an epidemic-prone vector-borne communicable disease caused by chikungunya virus (CHIKV). Due to the lack of appropriate treatment and vaccination, symptomatic or supportive treatments such as antipyretics, oral and tropical analgesics, and long-term anti-inflammatory therapy are the choices to manage chikungunya. This review aims to emphasize the potential role of a poly herbal Siddha formulation “Vatha Sura Kudineer (VSK)” used for the management of viral diseases in Siddha.
Materials and Methods: The scientific details including morphological description, phytochemical constituents, and their pharmacological studies along with Siddha perspectives were collected from books and published journals.
Results: This article provides comprehensive information of the ingredients of VSK, and it revealed their antiviral, antipyretic, anti-inflammatory, analgesic, antimicrobial, immunomodulatory, and antioxidant properties. Piperine and gingerol are the natural bioenhancers present in Piper longum Linn. and Zingiber officinale Roscoe, which may be enhancing the absorption and bioavailability of the formulation.
Conclusion: As there is a lack of effective antiviral and anti-inflammatory drugs for the treatment of Chikungunya, VSK would be a cost effective, potent drug which needs to be explored. |
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|